Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.
Standard
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. / Bausch, Birke; Borozdin, Wiktor; Mautner, Viktor Felix; Hoffmann, Michael M; Boehm, Detlef; Robledo, Mercedes; Cascon, Alberto; Harenberg, Tomas; Schiavi, Francesca; Pawlu, Christian; Peczkowska, Mariola; Letizia, Claudio; Calvieri, Stefano; Arnaldi, Giorgio; Klingenberg-Noftz, Rolf D; Reisch, Nicole; Fassina, Ambrogio; Brunaud, Laurent; Walter, Martin A; Mannelli, Massimo; MacGregor, Graham; Palazzo, F Fausto; Barontini, Marta; Walz, Martin K; Kremens, Bernhard; Brabant, Georg; Pfäffle, Roland; Koschker, Ann-Cathrin; Lohoefner, Felix; Mohaupt, Markus; Gimm, Oliver; Jarzab, Barbara; McWhinney, Sarah R; Opocher, Giuseppe; Januszewicz, Andrzej; Kohlhase, Jürgen; Eng, Charis; Neumann, Hartmut P H.
In: J CLIN ENDOCR METAB, Vol. 92, No. 7, 7, 2007, p. 2784-2792.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.
AU - Bausch, Birke
AU - Borozdin, Wiktor
AU - Mautner, Viktor Felix
AU - Hoffmann, Michael M
AU - Boehm, Detlef
AU - Robledo, Mercedes
AU - Cascon, Alberto
AU - Harenberg, Tomas
AU - Schiavi, Francesca
AU - Pawlu, Christian
AU - Peczkowska, Mariola
AU - Letizia, Claudio
AU - Calvieri, Stefano
AU - Arnaldi, Giorgio
AU - Klingenberg-Noftz, Rolf D
AU - Reisch, Nicole
AU - Fassina, Ambrogio
AU - Brunaud, Laurent
AU - Walter, Martin A
AU - Mannelli, Massimo
AU - MacGregor, Graham
AU - Palazzo, F Fausto
AU - Barontini, Marta
AU - Walz, Martin K
AU - Kremens, Bernhard
AU - Brabant, Georg
AU - Pfäffle, Roland
AU - Koschker, Ann-Cathrin
AU - Lohoefner, Felix
AU - Mohaupt, Markus
AU - Gimm, Oliver
AU - Jarzab, Barbara
AU - McWhinney, Sarah R
AU - Opocher, Giuseppe
AU - Januszewicz, Andrzej
AU - Kohlhase, Jürgen
AU - Eng, Charis
AU - Neumann, Hartmut P H
PY - 2007
Y1 - 2007
N2 - BACKGROUND: Neurofibromatosis type 1 (NF1) is a pheochromocytoma-associated syndrome. Because of the low prevalence of pheochromocytoma in NF1, we ascertained subjects by pheochromocytoma that also had NF1 in the hope of describing the germline NF1 mutational spectra of NF1-related pheochromocytoma. MATERIALS AND METHODS: An international registry for NF1-pheochromocytomas was established. Mutation scanning was performed using denaturing HPLC for intragenic variation and quantitative PCR for large deletions. Loss-of-heterozygosity analysis using markers in and around NF1 was performed. RESULTS: There were 37 eligible subjects (ages 14-70 yr). Of 21 patients with corresponding tumor available, 67% showed somatic loss of the nonmutated allele at the NF1 locus vs. 0 of 12 sporadic tumors (P = 0.0002). Overall, 86% of the 37 patients had exonic or splice site mutations, 14% large deletions or duplications; 79% of the mutations are novel. The cysteine-serine rich domain (CSR) was affected in 35% but the RAS GTPase activating protein domain (RGD) in only 13%. There did not appear to be an association between any clinical features, particularly pheochromocytoma presentation and severity, and NF1 mutation genotype. CONCLUSIONS: The germline NF1 mutational spectra comprise intragenic mutations and deletions in individuals with pheochromocytoma and NF1. NF1 mutations tended to cluster in the CSR over the RAS-GAP domain, suggesting that CSR plays a more prominent role in individuals with NF1-pheochromocytoma than in NF1 individuals without this tumor. Loss-of-heterozygosity of NF1 markers in NF1-related pheochromocytoma was significantly more frequent than in sporadic pheochromocytoma, providing further molecular evidence that pheochromocytoma is a true component of NF1.
AB - BACKGROUND: Neurofibromatosis type 1 (NF1) is a pheochromocytoma-associated syndrome. Because of the low prevalence of pheochromocytoma in NF1, we ascertained subjects by pheochromocytoma that also had NF1 in the hope of describing the germline NF1 mutational spectra of NF1-related pheochromocytoma. MATERIALS AND METHODS: An international registry for NF1-pheochromocytomas was established. Mutation scanning was performed using denaturing HPLC for intragenic variation and quantitative PCR for large deletions. Loss-of-heterozygosity analysis using markers in and around NF1 was performed. RESULTS: There were 37 eligible subjects (ages 14-70 yr). Of 21 patients with corresponding tumor available, 67% showed somatic loss of the nonmutated allele at the NF1 locus vs. 0 of 12 sporadic tumors (P = 0.0002). Overall, 86% of the 37 patients had exonic or splice site mutations, 14% large deletions or duplications; 79% of the mutations are novel. The cysteine-serine rich domain (CSR) was affected in 35% but the RAS GTPase activating protein domain (RGD) in only 13%. There did not appear to be an association between any clinical features, particularly pheochromocytoma presentation and severity, and NF1 mutation genotype. CONCLUSIONS: The germline NF1 mutational spectra comprise intragenic mutations and deletions in individuals with pheochromocytoma and NF1. NF1 mutations tended to cluster in the CSR over the RAS-GAP domain, suggesting that CSR plays a more prominent role in individuals with NF1-pheochromocytoma than in NF1 individuals without this tumor. Loss-of-heterozygosity of NF1 markers in NF1-related pheochromocytoma was significantly more frequent than in sporadic pheochromocytoma, providing further molecular evidence that pheochromocytoma is a true component of NF1.
M3 - SCORING: Zeitschriftenaufsatz
VL - 92
SP - 2784
EP - 2792
JO - J CLIN ENDOCR METAB
JF - J CLIN ENDOCR METAB
SN - 0021-972X
IS - 7
M1 - 7
ER -
